Darolutamide
Back to searchMolecule Structure
Scientific Name
Darolutamide
Description of the Drug
Darolutamide is an androgen receptor antagonist used for castration-resistant, non-metastatic prostate cancer and metastatic hormone-sensitive prostate cancer.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB12941
http://www.drugbank.ca/drugs/DB12941
Brand Name(s)
Nubeqa
Company Owner(s)
Bayer Healthcare Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Androgen Receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL1871 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL1814935 | |
| DrugBank | DB12941 | |
| PubChem | 67171867 | |
| Nikkaji | J3.501.129C | |
| BindingDB | 309979 | |
| ChemicalBook | CB43052901 | |
| Guide to Pharmacology | 10439 | |
| rxnorm | NUBEQA | DAROLUTAMIDE |
